S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
Log in
NASDAQ:SNGX

Soligenix News Headlines

$1.53
-0.17 (-10.00 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.38
Now: $1.53
$1.66
50-Day Range
$1.43
MA: $1.73
$2.35
52-Week Range
$1.21
Now: $1.53
$3.07
Volume4.54 million shs
Average Volume5.55 million shs
Market Capitalization$48.17 million
P/E RatioN/A
Dividend YieldN/A
Beta1.42

Headlines

Soligenix (NASDAQ SNGX) News Headlines Today

Source:
SourceHeadline
Soligenix (NASDAQ:SNGX) Stock Price Down 10%Soligenix (NASDAQ:SNGX) Stock Price Down 10%
americanbankingnews.com - March 5 at 8:36 PM
Looking For The Best Penny Stocks To Watch? 3 To Know Right Now - StreetInsider.comLooking For The Best Penny Stocks To Watch? 3 To Know Right Now - StreetInsider.com
streetinsider.com - March 4 at 5:51 PM
The Daily Biotech Pulse: FDA Nod For Pfizer, Kiniksa Rises On Commercialization Pact With Regeneron, Bio-Techne To Buy Diagnostic Company - BenzingaThe Daily Biotech Pulse: FDA Nod For Pfizer, Kiniksa Rises On Commercialization Pact With Regeneron, Bio-Techne To Buy Diagnostic Company - Benzinga
benzinga.com - March 4 at 12:51 PM
Soligenix (NASDAQ:SNGX) Shares Gap Up to $1.61Soligenix (NASDAQ:SNGX) Shares Gap Up to $1.61
americanbankingnews.com - March 4 at 11:40 AM
Soligenix Announces Positive Progress in the Pre-clinical Development of its COVID-19 Vaccine - Yahoo FinanceSoligenix Announces Positive Progress in the Pre-clinical Development of its COVID-19 Vaccine - Yahoo Finance
finance.yahoo.com - March 4 at 7:51 AM
Soligenix Announces Positive Progress in the Pre-clinical Development of its COVID-19 VaccineSoligenix Announces Positive Progress in the Pre-clinical Development of its COVID-19 Vaccine
finance.yahoo.com - March 4 at 7:51 AM
Soligenix Shares Rally On Positive Preclinical Data For COVID-19 Vaccine CandidateSoligenix Shares Rally On Positive Preclinical Data For COVID-19 Vaccine Candidate
benzinga.com - March 4 at 7:28 AM
Soligenix (NASDAQ:SNGX) Trading Down 7.7%Soligenix (NASDAQ:SNGX) Trading Down 7.7%
americanbankingnews.com - February 25 at 9:40 PM
SOLIGENIX, INC. (SNGX) - Soligenix Issues Shareholder Letter, Highlights Upcoming Catalysts - BenzingaSOLIGENIX, INC. (SNGX) - Soligenix Issues Shareholder Letter, Highlights Upcoming Catalysts - Benzinga
benzinga.com - February 25 at 3:24 AM
Soligenix (NASDAQ:SNGX) Trading 5.2% Higher Soligenix (NASDAQ:SNGX) Trading 5.2% Higher
americanbankingnews.com - February 24 at 10:38 PM
Soligenix Provides Important Highlights and Upcoming Catalysts in Corporate Update Letter - Yahoo FinanceSoligenix Provides Important Highlights and Upcoming Catalysts in Corporate Update Letter - Yahoo Finance
finance.yahoo.com - February 24 at 7:21 AM
Soligenix Provides Important Highlights and Upcoming Catalysts in Corporate Update LetterSoligenix Provides Important Highlights and Upcoming Catalysts in Corporate Update Letter
finance.yahoo.com - February 24 at 7:21 AM
Soligenix is Ready for Commercialization of SGX301 (HyBryte(TM)); FDA Has Approval Process on Fast Track - Yahoo FinanceSoligenix is Ready for Commercialization of SGX301 (HyBryte(TM)); FDA Has Approval Process on Fast Track - Yahoo Finance
finance.yahoo.com - February 23 at 11:19 AM
Soligenix is Ready for Commercialization of SGX301 (HyBryte(TM)); FDA Has Approval Process on Fast TrackSoligenix is Ready for Commercialization of SGX301 (HyBryte(TM)); FDA Has Approval Process on Fast Track
finance.yahoo.com - February 23 at 11:19 AM
Soligenix (NASDAQ:SNGX) Trading Down 8.9%Soligenix (NASDAQ:SNGX) Trading Down 8.9%
americanbankingnews.com - February 17 at 8:36 PM
Soligenix (NASDAQ:SNGX) Shares Gap Up to $2.14Soligenix (NASDAQ:SNGX) Shares Gap Up to $2.14
americanbankingnews.com - February 16 at 3:02 PM
Soligenix to Present at the 2021 BIO CEO & Investor Digital Conference - PRNewswireSoligenix to Present at the 2021 BIO CEO & Investor Digital Conference - PRNewswire
prnewswire.com - February 12 at 12:05 AM
Soligenix to Present at the 2021 BIO CEO & Investor Digital Conference - Yahoo FinanceSoligenix to Present at the 2021 BIO CEO & Investor Digital Conference - Yahoo Finance
finance.yahoo.com - February 11 at 2:05 PM
Soligenix to Present at the 2021 BIO CEO & Investor Digital ConferenceSoligenix to Present at the 2021 BIO CEO & Investor Digital Conference
finance.yahoo.com - February 11 at 9:04 AM
Soligenixs Upcoming Catalysts Highlight Growth Potential as it Sheds Light on its Commercialization of SGX301 - Yahoo FinanceSoligenix's Upcoming Catalysts Highlight Growth Potential as it Sheds Light on its Commercialization of SGX301 - Yahoo Finance
finance.yahoo.com - February 9 at 9:27 AM
Soligenixs Upcoming Catalysts Highlight Growth Potential as it Sheds Light on its Commercialization of SGX301Soligenix's Upcoming Catalysts Highlight Growth Potential as it Sheds Light on its Commercialization of SGX301
finance.yahoo.com - February 9 at 9:27 AM
Soligenix Receives Hong Kong Patent for Therapeutic Use of Synthetic Hypericin to Treat Cutaneous T-Cell Lymphoma - MarketWatchSoligenix Receives Hong Kong Patent for Therapeutic Use of Synthetic Hypericin to Treat Cutaneous T-Cell Lymphoma - MarketWatch
marketwatch.com - February 2 at 9:17 AM
Soligenix, Inc. (SNGX) Receives Hong Kong Patent for Therapeutic Use of Synthetic Hypericin to Treat Cutaneous T-Cell Lymphoma - StreetInsider.comSoligenix, Inc. (SNGX) Receives Hong Kong Patent for Therapeutic Use of Synthetic Hypericin to Treat Cutaneous T-Cell Lymphoma - StreetInsider.com
streetinsider.com - February 1 at 6:52 PM
Soligenix Receives Hong Kong Patent for Therapeutic Use of Synthetic Hypericin to Treat Cutaneous T-Cell LymphomaSoligenix Receives Hong Kong Patent for Therapeutic Use of Synthetic Hypericin to Treat Cutaneous T-Cell Lymphoma
finance.yahoo.com - February 1 at 8:52 AM
SNGX: Provides Update on SGX301 Commercialization Plan…SNGX: Provides Update on SGX301 Commercialization Plan…
finance.yahoo.com - January 28 at 1:23 PM
Soligenix Poised to Announce US Commercialization Plans of SGX301 in the Treatment of Cutaneous T-Cell Lymphoma - Yahoo FinanceSoligenix Poised to Announce US Commercialization Plans of SGX301 in the Treatment of Cutaneous T-Cell Lymphoma - Yahoo Finance
finance.yahoo.com - January 25 at 12:43 PM
Soligenix Poised to Announce US Commercialization Plans of SGX301 in the Treatment of Cutaneous T-Cell LymphomaSoligenix Poised to Announce US Commercialization Plans of SGX301 in the Treatment of Cutaneous T-Cell Lymphoma
finance.yahoo.com - January 25 at 12:43 PM
Soligenix Announces Investor Webcast Event: U.S. Commercialization of SGX301 in the Treatment of Cutaneous T-Cell Lymphoma - MarketWatchSoligenix Announces Investor Webcast Event: U.S. Commercialization of SGX301 in the Treatment of Cutaneous T-Cell Lymphoma - MarketWatch
marketwatch.com - January 21 at 10:17 PM
Soligenix Announces Investor Webcast Event: U.S. Commercialization of SGX301 in the Treatment of Cutaneous T-Cell Lymphoma - Yahoo FinanceSoligenix Announces Investor Webcast Event: U.S. Commercialization of SGX301 in the Treatment of Cutaneous T-Cell Lymphoma - Yahoo Finance
finance.yahoo.com - January 19 at 6:11 PM
Soligenix inks supply and distribution deal for SGX301 companion light device in cancer - Seeking AlphaSoligenix inks supply and distribution deal for SGX301 companion light device in cancer - Seeking Alpha
seekingalpha.com - January 7 at 7:58 PM
Soligenix Announces Strategic Partnership with Daavlin for Supply and Distribution of the SGX301 Companion Light Device in the Treatment of Cutaneous T-Cell Lymphoma - PRNewswireSoligenix Announces Strategic Partnership with Daavlin for Supply and Distribution of the SGX301 Companion Light Device in the Treatment of Cutaneous T-Cell Lymphoma - PRNewswire
prnewswire.com - January 7 at 9:57 AM
Soligenix Announces Strategic Partnership with Daavlin for Supply and Distribution of the SGX301 Companion Light Device in the Treatment of Cutaneous T-Cell LymphomaSoligenix Announces Strategic Partnership with Daavlin for Supply and Distribution of the SGX301 Companion Light Device in the Treatment of Cutaneous T-Cell Lymphoma
finance.yahoo.com - January 7 at 9:57 AM
Soligenix, Inc. (SNGX) Secures $1.5M NIH Small Business Innovation Research Award to Advance COVID-19 Vaccine Development - StreetInsider.comSoligenix, Inc. (SNGX) Secures $1.5M NIH Small Business Innovation Research Award to Advance COVID-19 Vaccine Development - StreetInsider.com
streetinsider.com - December 28 at 7:30 AM
Soligenix Announces $1.5 Million NIH Small Business Innovation Research Award Advancing COVID-19 Vaccine Development - PRNewswireSoligenix Announces $1.5 Million NIH Small Business Innovation Research Award Advancing COVID-19 Vaccine Development - PRNewswire
prnewswire.com - December 28 at 7:30 AM
Soligenix Announces $1.5 Million NIH Small Business Innovation Research Award Advancing COVID-19 Vaccine DevelopmentSoligenix Announces $1.5 Million NIH Small Business Innovation Research Award Advancing COVID-19 Vaccine Development
finance.yahoo.com - December 28 at 7:30 AM
Mid-Afternoon Market Update: Dow Falls 120 Points; Soligenix Shares PlummetMid-Afternoon Market Update: Dow Falls 120 Points; Soligenix Shares Plummet
benzinga.com - December 24 at 7:32 AM
SNGX: Phase 3 Trial of SGX942 Does Not Meet Primary Endpoint…SNGX: Phase 3 Trial of SGX942 Does Not Meet Primary Endpoint…
finance.yahoo.com - December 23 at 10:06 AM
Mid-Afternoon Market Update: Dow Falls 120 Points; Soligenix Shares Plummet - BenzingaMid-Afternoon Market Update: Dow Falls 120 Points; Soligenix Shares Plummet - Benzinga
benzinga.com - December 22 at 5:31 PM
BUZZ-U.S. STOCKS ON THE MOVE-Ocugen Inc, Peloton Interactive, Apple - NasdaqBUZZ-U.S. STOCKS ON THE MOVE-Ocugen Inc, Peloton Interactive, Apple - Nasdaq
nasdaq.com - December 22 at 12:29 PM
BUZZ-U.S. STOCKS ON THE MOVE-Apple, Ocugen Inc, Soligenix Inc - NasdaqBUZZ-U.S. STOCKS ON THE MOVE-Apple, Ocugen Inc, Soligenix Inc - Nasdaq
nasdaq.com - December 22 at 12:29 PM
Soligenix Announces Topline Results from its Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients - Yahoo FinanceSoligenix Announces Topline Results from its Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients - Yahoo Finance
finance.yahoo.com - December 22 at 12:29 PM
Soligenix Announces Topline Results from its Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer PatientsSoligenix Announces Topline Results from its Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients
finance.yahoo.com - December 22 at 7:28 AM
Soligenix Announces $20 Million Strategic Convertible Debt Financing Agreement with Pontifax Medison Debt Financing - PRNewswireSoligenix Announces $20 Million Strategic Convertible Debt Financing Agreement with Pontifax Medison Debt Financing - PRNewswire
prnewswire.com - December 16 at 9:22 AM
Soligenix Announces $20 Million Strategic Convertible Debt Financing Agreement with Pontifax Medison Debt FinancingSoligenix Announces $20 Million Strategic Convertible Debt Financing Agreement with Pontifax Medison Debt Financing
finance.yahoo.com - December 16 at 9:22 AM
Soligenix, Inc. COVID-19 Vaccine Candidate, CiVax, Could Be a More Viable Alternative to Moderna and Pfizer - Yahoo FinanceSoligenix, Inc. COVID-19 Vaccine Candidate, CiVax, Could Be a More Viable Alternative to Moderna and Pfizer - Yahoo Finance
finance.yahoo.com - December 9 at 9:08 AM
Soligenix Demonstrates Extended Protection with its RiVax® Ricin Toxin Vaccine - PRNewswireSoligenix Demonstrates Extended Protection with its RiVax® Ricin Toxin Vaccine - PRNewswire
prnewswire.com - December 9 at 4:06 AM
Soligenix Demonstrates Extended Protection with its RiVax® Ricin Toxin Vaccine - Yahoo FinanceSoligenix Demonstrates Extended Protection with its RiVax® Ricin Toxin Vaccine - Yahoo Finance
finance.yahoo.com - December 8 at 6:05 PM
Soligenix Demonstrates Extended Protection with its RiVax® Ricin Toxin VaccineSoligenix Demonstrates Extended Protection with its RiVax® Ricin Toxin Vaccine
prnewswire.com - December 8 at 8:15 AM
SOLIGENIX INCSOLIGENIX INC
fool.com - November 27 at 12:28 AM
Pfizer and Moderna COVID-19 Vaccine Candidates Are Promising, but Soligenixs Civax (TM) May Be a Better Alternative - Yahoo FinancePfizer and Moderna COVID-19 Vaccine Candidates Are Promising, but Soligenix's Civax (TM) May Be a Better Alternative - Yahoo Finance
finance.yahoo.com - November 17 at 10:30 PM
This page was last updated on 3/7/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.